Digital biomarkers are healthcare’s next frontier

Sunny Kumar
Contributor




Share on Twitter





Sunny Kumar, MD, MBA is a partner at GSR Ventures, an early-stage venture capital firm focused on healthcare technology with more than $3.5 billion under management.


Blood pressure, body temperature, hemoglobin A1c levels and other biomarkers have been used for decades to track disease. While this information is essential for chronic condition management, these and many other physiological measurements are typically captured only periodically, making it difficult to reliably detect earl

リンク元